30
Participants
Start Date
June 9, 2020
Primary Completion Date
March 31, 2021
Study Completion Date
August 31, 2021
AMG 334
30 subjects with rosacea will be allocated to receive monthly subcutaneous injections of 140 mg erenumab at three time points (week 0, week 4, week 8)
RECRUITING
Danish Headache Center, Glostrup Municipality
Collaborators (1)
Danish Headache Center
OTHER
Novartis Pharmaceuticals
INDUSTRY
Herlev and Gentofte Hospital
OTHER
Messoud Ashina
OTHER